Scientists Meet in Valencia to Define the Path to Clinical Integration Valencia, Spain. June 9–10, 2026 Researchers, clinicians, and biotechnology innovators from around the world will gather in ...
Morning Overview on MSN
Spaceflight makes bacteriophages better at infecting and killing bacteria
Bacteriophage T7, a virus that preys on E. coli, becomes a more effective killer after spending time aboard the International ...
The pseudomonal infections clinical trial analysis report delivers important insights into ongoing research of 10+ pipeline ...
The research, published in Science Advances, brought together scientists from Otago and the Okinawa Institute of Science and Technology. The team closely examined the molecular structure of Bas63, a ...
Bacteriophages, or phages, are viruses that specifically infect bacteria. They are the most abundant biological entities on Earth, yet we are only starting to understand their profound impact on ...
Race for new antibiotics intensifies as WHO warns drug pipeline remains thin, and remains structurally unfit to support antibiotic innovation ...
In a recent narrative review published in the British Journal of Biomedical Science, researchers summarized the therapeutic approaches under development to tackle antimicrobial resistance (AMR).
Intravenous use as a QIDP for adjunct treatment of complicated bacteremia caused by Staphylococcus aureus QIDP Designation provides for five years of market exclusivity ...
First-ever randomized, placebo-controlled Phase 1 trial - published in The Lancet Microbe - supports SNIPR001’s safety, tolerability, and restriction to the gastrointestinal tract in healthy ...
The DNA foundation model Evo 2 has been published in the journal Nature. Trained on the DNA of over 100,000 species across ...
For years, treating gum disease has meant scraping away plaque, cutting out damaged tissue or turning to antibiotics that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results